Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial

INTRODUCTION: Diabetic kidney disease (DKD) is a prevalent and costly complication of diabetes with limited therapeutic options, being the leading cause of end-stage kidney disease in most developed regions. Recent big data studies showed that add-on Chinese medicine (CM) led to a reduced risk of en...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kam Wa, Kwong, Alfred Siu Kei, Tsui, Pun Nang, Cheung, Simon Chi Yuen, Chan, Gary Chi Wang, Choi, Wing Fai, Yiu, Wai Han, Zhang, Yanbo, Wong, Michelle Man-Ying, Zhang, Zhang-Jin, Tan, Kathryn Choon Beng, Lao, Lixing, Tang, Sydney Chi Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Complementary Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805381/
https://www.ncbi.nlm.nih.gov/pubmed/33436470
http://dx.doi.org/10.1136/bmjopen-2020-042686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805381/
https://www.ncbi.nlm.nih.gov/pubmed/33436470
http://dx.doi.org/10.1136/bmjopen-2020-042686

Ejemplares similares